Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Fernandez, Ana M.a; b | Hervas, Rubena | Dominguez-Fraile, Manuela; b | Garrido, Victoria Navarrob; c | Gomez-Gutierrez, Patriciad | Vega, Miguele | Vitorica, Javierb; c | Perez, Juan J.d | Torres Aleman, Ignacioa; b; *
Affiliations: [a] Cajal Institute, CSIC, Madrid, Spain | [b] CIBERNED, Madrid, Spain | [c] IBIS, CSIC-Universidad de Sevilla, Sevilla, Spain | [d] GBMI, Universitat Politécnica de Catalunya, Barcelona, Spain | [e] Allinky Biopharma, Madrid, Spain
Correspondence: [*] Correspondence to: Ignacio Torres Aleman, Cajal Institute, Avda Dr Arce 37, 28002 Madrid, Spain. Tel.: +34 915854723; Fax: +34 915854754; E-mail: [email protected].
Abstract: Astrocytes actively participate in neuro-inflammatory processes associated to Alzheimer’s disease (AD), and other brain pathologies. We recently showed that an astrocyte-specific intracellular signaling pathway involving an interaction of the phosphatase calcineurin with the transcription factor FOXO3 is a major driver in AD-associated pathological inflammation, suggesting a potential new druggable target for this devastating disease. We have now developed decoy molecules to interfere with calcineurin/FOXO3 interactions, and tested them in astrocytes and neuronal co-cultures exposed to amyloid-β (Aβ) toxicity. We observed that interference of calcineurin/FOXO3 interactions exerts a protective action against Aβ-induced neuronal death and favors the production of a set of growth factors that we hypothesize form part of a cytoprotective pathway to resolve inflammation. Furthermore, interference of the Aβ-induced interaction of calcineurin with FOXO3 by decoy compounds significantly decreased amyloid-β protein precursor (AβPP) synthesis, reduced the AβPP amyloidogenic pathway, resulting in lower Aβ levels, and blocked the expression of pro-inflammatory cytokines TNFα and IL-6 in astrocytes. Collectively, these data indicate that interrupting pro-inflammatory calcineurin/FOXO3 interactions in astrocytes triggered by Aβ accumulation in brain may constitute an effective new therapeutic approach in AD. Future studies with intranasal delivery, or brain barrier permeable decoy compounds, are warranted.
Keywords: Alzheimer’s disease, astrocytes, calcineurin, decoy compounds, FOXO
DOI: 10.3233/JAD-160149
Journal: Journal of Alzheimer's Disease, vol. 52, no. 4, pp. 1471-1478, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]